purimmun 50 mg
2care4 generics aps - merkaptopurin - tablett - 50 mg
buprefarm 30 mikrog/ time
orifarm generics a/s - buprenorfin - depotplaster - 30 mikrog/ time
calcipotriol/betamethasone orifarm 50 mikrog/ g / 0.5 mg/ g
orifarm generics a/s - kalsipotriolmonohydrat / betametasondipropionat - gel - 50 mikrog/ g / 0.5 mg/ g
esomeprazol orifarm 10 mg
orifarm generics a/s - esomeprazolmagnesium - enterogranulat til mikstur, suspensjon i dosepose - 10 mg
oxycodone orifarm 1 mg/ ml
orifarm generics a/s - oksykodonhydroklorid - mikstur, oppløsning - 1 mg/ ml
oxycodone orifarm 10 mg/ ml
orifarm generics a/s - oksykodonhydroklorid - mikstur, oppløsning - 10 mg/ ml
urisotam 6 mg / 0.4 mg
2care4 generics aps - solifenacinsuksinat / tamsulosinhydroklorid - tablett med modifisert frisetting - 6 mg / 0.4 mg
isotretinoin orifarm 10 mg
orifarm generics (2) - isotretinoin - kapsel, myk - 10 mg
paroxetin actavis 20 mg
actavis group ptc ehf (1) - paroksetinhydroklorid - tablett, filmdrasjert - 20 mg
ximluci
stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - Øyemidler - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).